SCHEMBL19239124

SCHEMBL19239124

c1ccc(-c2cc(-c3ccc4c(c3)Cc3ccc(N(c5ccccc5)c5ccc6c(c5)-c5ccccc5C6)cc3-4)cc(N(c3ccccc3)c3ccccc3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.40
MMP13 P45452 1/20 0.40
TDP2 O95551 1/20 0.40
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
HPGD P15428 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 4/20 0.39
CYP3A4 P08684 4/20 0.39
CYP2C19 P33261 3/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39
HSD17B10 Q99714 2/20 0.39
SRD5A2 P31213 1/20 0.38
CNR1 P21554 1/20 0.38
SLC6A2 P23975 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21730739 0.92 CNR1 (0.43) MMP12MMP13TDP2ALDH1A1MAPT
SCHEMBL24114021 0.92 ALDH1A1 (0.39) MMP12MMP13TDP2ALDH1A1MAPT
SCHEMBL19239125 0.89 CYP1A2 (0.43) MMP12MMP13TDP2ALDH1A1MAPT
SCHEMBL14016099 0.89 CYP1A2 (0.45) MMP12MMP13TDP2ALDH1A1MAPT
SCHEMBL19885357 0.88 MAPT (0.40) MMP12MMP13ALDH1A1MAPTHPGD
SCHEMBL13608539 0.86 CYP1A2 (0.47) ALDH1A1MAPTHPGDSMN1; SMN2NPC1
SCHEMBL5446075 0.86 CYP1A2 (0.49) MMP12MMP13TDP2ALDH1A1MAPT
SCHEMBL24923295 0.86 CYP1A2 (0.49) MMP12MMP13TDP2ALDH1A1MAPT
SCHEMBL804482 0.86 CYP1A2 (0.49) MMP12MMP13TDP2ALDH1A1MAPT
SCHEMBL26240139 0.86 MAPT (0.43) MMP12MMP13TDP2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170237013-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-08-17 US disclosed
US-20170237013-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170237013-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF EML4, EBPL, NFE2L2 MMP12 3210/4885MMP13 4684/4885TDP2 2579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.